The manufacturer of professional, medical, industrial and commercial products and services will report its earnings results before the market open on Tuesday.
Analysts surveyed by Thomson Reuters are expecting the company to report earnings of $1.27 per share on revenue of $6.01 billion.
Danaher reported earnings of $1.04 per share on revenue of $5.4 billion during the 2014 fourth quarter.
Last month, the company reported that it has experienced weaker orders within its industrial-oriented businesses.
"This has been a remarkable year for Danaher," CEO Thomas Joyce said in December. "Year-to-date, we have completed the largest acquisition in our history with Pall, announced our 2016 separation into two independent, publicly traded companies with Fortive, and driven solid core revenue growth, operating margin expansion and free cash flow in a difficult global environment."
Separately, recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
TheStreet Ratings rates this stock as a "buy" with a ratings score of A-. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.
You can view the full analysis from the report here: DHR